Figure 1.
Clinical pathway for LNG-IUS and usual medical treatment.
Table 1.
Cost data used in the analysis.
Table 2.
Health state utility data used in the model.
Table 3.
Probability parameters used in the analysis.
Table 4.
Base case and deterministic sensitivity analysis results using EQ-5D.
Figure 2.
Results of the probabilistic sensitivity analysis (EQ-5D).
Figure 3.
Cost-effectiveness acceptability curves for usual medical treatment and LNG-IUS using EQ-5D.
Table 5.
Sensitivity analysis 4 results using SF-6D.
Figure 4.
Results of the probabilistic sensitivity analysis (SF-6D).
Figure 5.
Cost-effectiveness acceptability curves for usual medical treatment and LNG-IUS using SF-6D.